Journal of Molecular Neuroscience

, Volume 56, Issue 2, pp 349–362 | Cite as

Naringin Abrogates Cisplatin-Induced Cognitive Deficits and Cholinergic Dysfunction Through the Down-Regulation of AChE Expression and iNOS Signaling Pathways in Hippocampus of Aged Rats

  • Yassine Chtourou
  • Brahim Gargouri
  • Mohammed Kebieche
  • Hamadi FetouiEmail author


Chemotherapy-related cognitive deficits are a major neurological problem, but the underlying mechanisms are unclear. However, very few studies have looked at the possible ways of preventing this stress-induced deficit. Thus, we investigated the relationship between cisplatin (Cis) exposure to acetylcholinesterase, ATPase, oxidative stress biomarkers, and impaired behavior performance and the possible protecting mechanism of naringin (Nar), a plant-derived flavonoid, in aged rats. The experimental procedures were divided in two sets of experiments. In the first, the animals were divided into four groups: vehicle, Nar 25 mg/kg, Nar 50 mg/kg, and Nar 100 mg/kg. In the second, the animals were divided into four groups: Cis (5 mg kg−1 week−1 for five consecutive weeks), Cis plus Nar (25 mg/kg), Cis plus Nar (50 mg/kg), and Cis plus Nar (100 mg/kg). Results showed that Cis exposure leads to the increase in acetylcholinesterase associated with a significant increase in mRNA levels of acetylcholinesterase and the inducible nitric oxide synthase (iNOS) in the hippocampus. Moreover, a decrease in membrane-bound ATPase enzyme activities and enzymatic and nonenzymatic antioxidant activities in the hippocampus and an increase in the levels of malondialdehyde (MDA), protein carbonyls (PCO), nitrite formation (NO), and reactive oxygen species (ROS) levels were found. Further, Cis-induced neuronal alterations were evidenced by impairment behavioral performance. Treatment with Nar significantly and dose-dependently prevented all the behavioral, biochemical, and molecular alterations in aged rats treated with cisplatin. Thus, findings from the current study demonstrate the possible involvement of oxidative-stress-mediated inflammatory signaling in Cis-induced cognitive dysfunction and also suggests the effectiveness of naringin in preventing cognitive deficits in chemotherapy-induced peripheral neuropathy.


Cisplatin Aged rat Hippocampus Cognitive deficit Cholinergic function Oxidative stress 



The present work was supported by the grants of DGRST (Appui a la Recherche Universitaire de base, ARUB, UR11ES70) Tunisia.


  1. Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–126PubMedGoogle Scholar
  2. Albers JW, Chaudhry V, Cavaletti G, Donehower RC (2011) Interventions for preventing neuropathy caused by cisplatin and related compounds. Cochrane Database Syst Rev 2:1–49Google Scholar
  3. Areti A, Yerra VG, Naidu VGM, Kumar A (2014) Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy. Redoxol Biol 2:289–295CrossRefGoogle Scholar
  4. Argyriou AA, Bruna J, Marmiroli P, Cavaletti G (2012) Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. Crit Rev Oncol Hematol 82:51–77PubMedCrossRefGoogle Scholar
  5. Baluchnejadmojarad T, Roghani M (2006) Effect of naringenin on intracerebroventricular streptozotocin-induced cognitive deficits in rat, a behavioral analysis. Pharmacology 78:193–197PubMedCrossRefGoogle Scholar
  6. Benavente-Garcia O, Castillo J (2008) Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity. J Agric Food Chem 56:6185–6205PubMedCrossRefGoogle Scholar
  7. Blokland A (1995) Acetylcholine, a neurotransmitter for learning and memory. Brain Res Rev 21:285–300PubMedCrossRefGoogle Scholar
  8. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248PubMedCrossRefGoogle Scholar
  9. Brouwers EE, Huitema AD, Boogerd W, Beijnen JH, Schellens JH (2009) Persistent neuropathy after treatment with cisplatin and oxaliplatin. Acta Oncol 48:832–841PubMedCrossRefGoogle Scholar
  10. Campbell KC, Rybak LP, Meech RP, Hughes LD (1996) Methionine provides excellent protection from cisplatin ototoxicity in the rat. Hear Res 102:90–98PubMedCrossRefGoogle Scholar
  11. Campbell KC, Meech RP, Rybak LP, Hughes LFD (1999) Methionine protects against cisplatin damage to the stria vascularis. Hear Res 138:13–28PubMedCrossRefGoogle Scholar
  12. Carfagna MA, Ponsler GD, Muhoberac BB (1996) Inhibition of ATPase activity in rat synaptic plasma membranes by simultaneousexposure to metals. Chem Biol Interact 100:53–65PubMedCrossRefGoogle Scholar
  13. Carozzi V, Chiorazzi A, Canta A (2009) Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity. Eur J Cancer 45:656–665PubMedCrossRefGoogle Scholar
  14. Chirino YI, Pedraza-Chaverri J (2009) Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp Toxicol Pathol 61:223PubMedCrossRefGoogle Scholar
  15. Choe SC, Kim HS, Jeong TS, Bok SH, Park YB (2001) Naringin has an antiatherogenic effect with the inhibition of intercellular adhesion molecule-1 in hypercholesterolemic rabbits. J Cardiovasc Pharmacol 38:947–955PubMedCrossRefGoogle Scholar
  16. Chtourou Y, Fetoui H, Garoui EM, Boudawara T, Zeghal N (2012) Improvement of cerebellum redox states and cholinergic functions contribute to the beneficial effects of silymarin against manganese-induced neurotoxicity. Neurochem Res 37:469–479PubMedCrossRefGoogle Scholar
  17. Chtourou Y, Fetoui H, Jemai R, Ben Slima A, Makni M, Gdoura R (2015) Naringenin reduces cholesterol-induced hepatic inflammation in rats by modulating matrix metalloproteinases-2, 9 via inhibition of nuclear factor κB pathway. Eur J Pharmacol 746:96–105PubMedCrossRefGoogle Scholar
  18. Draper HH, Hadley M (1990) Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 186:421–431PubMedGoogle Scholar
  19. Driver AS, Kodavanti PS, Mundy WR (2000) Age related changes in reactive oxygen species production in rat brain homogenates. Neurotoxicol Teratol 22:175–181PubMedCrossRefGoogle Scholar
  20. Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–77PubMedCrossRefGoogle Scholar
  21. Ellman GL, Courtney KD, Andres V, Feather-Stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95PubMedCrossRefGoogle Scholar
  22. Englander EW (2013) DNA damage response in peripheral nervous system: coping with cancer therapy-induced DNA lesions. DNA Repair 12:685–690PubMedCentralPubMedCrossRefGoogle Scholar
  23. Flohe L, Gunzler WA (1984) Assays of glutathione peroxidase. Methods Enzymol 105:114–121PubMedGoogle Scholar
  24. Franzon R, Lamers ML, Stefanello FM, Wannmacher CM, Wajner M, Wyse AT (2003) Evidence that oxidative stress is involved in the inhibitory effect of proline on Na(+), K(+)-ATPase activity in synaptic plasma membrane of rat hippocampus. Int J Dev Neurosci 21:303–307PubMedCrossRefGoogle Scholar
  25. Gaur V, Aggarwal A, Kumar A (2009) Protective effect of naringin against ischemic reperfusion cerebral injury: possible neurobehavioral, biochemical and cellular alterations in rat brain. Eur J Pharmacol 616:147–154PubMedCrossRefGoogle Scholar
  26. Gay C, Collins J, Gebicki JM (1999) Hydroperoxide assay with the ferric-xylenol orange complex. Anal Biochem 273:149–155PubMedCrossRefGoogle Scholar
  27. Gill JS, Windebank AJ (1998) Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle. J Clin Invest 101:2842–2850PubMedCentralPubMedCrossRefGoogle Scholar
  28. Golechha M, Sarangal V, Bhatia J, Chaudhry U, Saluja D, Arya SD (2014) Naringin ameliorates pentylenetetrazol-induced seizures and associated oxidative stress, inflammation, and cognitive impairment in rats: possible mechanisms of neuroprotection. Epilepsy Behav 41:98–102PubMedCrossRefGoogle Scholar
  29. Gopinath K, Prakash D, Sudhandiran G (2011) Neuroprotective effect of naringin, a dietary flavonoid against 3-nitropropionic acid-induced neuronal apoptosis. Neurochem Int 59:1066–1073PubMedCrossRefGoogle Scholar
  30. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 126:131–138PubMedCrossRefGoogle Scholar
  31. Hartman RE, Shah A, Fagan AM et al (2006) Pomegranate juicedecreases amyloid load and improves behavior in a mouse model of Alzheimer’s disease. Neurobiol Dis 24:506–515PubMedCrossRefGoogle Scholar
  32. Havekesa R, Abela T, Van der Zee EA (2011) The cholinergic system and neostriatal memory functions. Behav Brain Res 221:412–423CrossRefGoogle Scholar
  33. Hill A, Bergin P, Hanning F, Thompson P, Findlay M, Damianovich D, McKeage MJ (2010) Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability. BMC Cancer 10:451PubMedCentralPubMedCrossRefGoogle Scholar
  34. Jacques-Silva MC, Nogueira CW, Broch LC, Flores EM, Ro-cha JBT (2001) Diphenyl diselenide and ascorbic changes deposition of selenium and ascorbic in liver and brain of mice. Pharmacol Toxicol 88:119–125PubMedCrossRefGoogle Scholar
  35. Kandhare AD, Raygude KS, Ghosh P, Ghule AE, Bodhankar SL (2012) Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy. Fitoterapia 83:650–659PubMedCrossRefGoogle Scholar
  36. Kanno SI, Shouji A, Tomizawa A, Hiura T, Osanai Y, Ujibe M et al (2006) Inhibitory effect of naringin on lipopolysaccharide (LPS)-induced endotoxin shock in mice and nitric oxide production in RAW 264.7 macrophages. Life Sci 78:673–681PubMedCrossRefGoogle Scholar
  37. Kim SJ, Lim JY, Lee JN et al (2014) Activation of β-catenin by inhibitors of glycogen synthase kinase-3 ameliorates cisplatin-induced cytotoxicity and pro-inflammatory cytokine expression in HEI-OC1 cells. Toxicology 320:74–82PubMedCrossRefGoogle Scholar
  38. Krarup-Hansen A, Rietz B, Krarup C, Heydorn K, Rørth M, Schmalbruch H (1999) Histology and platinum content of sensory ganglia and sural nerves in patients treated with cisplatin and carboplatin: an autopsy study. Neuropathol Appl Neurobiol 25:29–40PubMedCrossRefGoogle Scholar
  39. Krarup-Hansen A, Helweg-Larsen S, Schmalbruch H, Rørth M, Krarup C (2007) Neuronal involvement in cisplatin neuropathy: prospective clinical and neurophysiological studies. Brain 130:1076–1088PubMedCrossRefGoogle Scholar
  40. Kumar A, Dogra S, Prakash A (2010a) Protective effect of naringin, a citrus flavonoid, against colchicine-induced cognitive dysfunction and oxidative damage in rats. J Med Food 13:976–984PubMedCrossRefGoogle Scholar
  41. Kumar A, Prakash A, Dogra S (2010b) Naringin alleviates cognitive impairment, mitochondrial dysfunction and oxidative stress induced by D-galactose in mice. Food Chem Toxicol 48:626–632PubMedCrossRefGoogle Scholar
  42. Kumar A, Singh RL, Babu GN (2010c) Cell death mechanisms inthe early stages of acute glutamate neurotoxicity. Neurosci Res 66:271–278PubMedCrossRefGoogle Scholar
  43. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186:464–478PubMedGoogle Scholar
  44. Li G, Liu W, Frenz D (2006) Cisplatin. ototoxicity to the rat inner ear, a role for HMG1 and iNOS. Neurotoxicology 27:22–30Google Scholar
  45. Mani M, Sadiq AMM (2014) Naringin modulates the impairment of memory, anxiety, locomotor, and emotionality behaviors in rats exposed to deltamethrin; apossible mechanism association with oxidative stress, acetylcholinesterase and ATPase. Biomed Prev Nutr 4:527–533CrossRefGoogle Scholar
  46. Marklund S, Marklund G (1974) Involvement of the superoxideanion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:469–474PubMedCrossRefGoogle Scholar
  47. Markman M (2006) Chemotherapy-induced peripheral neuropathy: underreported and underappreciated. Curr Pain Headache Rep 10:275–278PubMedCrossRefGoogle Scholar
  48. Mc Donald ES, Randon KR, Knight A, Windebank AJ (2005) Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: a potential mechanism of neurotoxicity. Neurobiol Dis 18:305CrossRefGoogle Scholar
  49. McDonald ES, Windebank AJ (2002) Cisplatin-induced apoptosis of DRG neurons involves bax redistribution and cytochrome c release but not fas receptor signaling. Neurobiol Dis 9:220–233PubMedCrossRefGoogle Scholar
  50. Meng N, Zhao J, Zhao B, Cheng Y, Wang W, Zhang Y et al (2008) A novel butyrolactone derivative inhibited smooth muscle cell migration and proliferation and maintained endothelial cell functions through selectively affecting Na, K-ATPase activity and mitochondria membrane potential during in vitro angiogenesis. J Cell Biochem 104:2123–2130PubMedCrossRefGoogle Scholar
  51. Paksoy M, Ayduran E, Sanlı A, Eken M, Aydın S, Oktay ZA (2011) The protective effects of intratympanic dexamethasone and vitamin E on cisplatin-induced ototoxicity are demonstrated in rats. Med Oncol 28:615–621PubMedCrossRefGoogle Scholar
  52. Paul E (2003) Gold acetylcholine modulation of neural systems involved in learning and memory neurobiol. Learn Mem 80:194–210CrossRefGoogle Scholar
  53. Pellow S, Chopin PH, File SE, Briley M (1985) Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149–167PubMedCrossRefGoogle Scholar
  54. Rajadurai M, Prince P (2009) Naringin ameliorates mitochondrial lipid peroxides, antioxidants and lipids in isoproterenol‐induced myocardial infarction in Wistar rats. Phytother Res 23:358–362PubMedCrossRefGoogle Scholar
  55. Rohn TT, Hinds TR, Vincenzi FF (1996) Inhibition of Ca2+-pump ATPase and the Na+/K+-pump ATPase by iron-generated free radicals. Protection by 6,7-dimethyl-2,4-DI-1-pyrrolidinyl-7H-pyrrolo[2,3-d] pyrimidine sulfate (U-89843D), a potent, novel, antioxidant/free radical scavenger. Biochem Pharmacol 51:471–476PubMedCrossRefGoogle Scholar
  56. Sachdeva AK, Kuha A, Chopra K (2014) Naringin ameliorates memory deficits in experimental paradigm of Alzheimer’s disease by attenuating mitochondrial dysfunction. Pharmacol Biochem Behav 127:101–110PubMedCrossRefGoogle Scholar
  57. Salvemini D, Little JW, Doyle T, Neumann WL (2011) Roles of reactive oxygen and nitrogen species in pain. Free Radic Biol Med 51:951–966PubMedCentralPubMedCrossRefGoogle Scholar
  58. Shabani M, Nazeri M, Parsania S, Razavinasab M, Zangiabadi N, Esmaeilpour K, Abareghi F (2012) Walnut consumption protects rats against cisplatin-induced neurotoxicity. NeuroToxicology 33:1314–1321PubMedCrossRefGoogle Scholar
  59. Shif O, Gillette K, Damkaoutis CM et al (2006) Effects of Ginkgo biloba administered after spatial learning on water maze and radial arm maze performance in young adult rats. Pharmacol Biochem Behav 84:17–25PubMedCrossRefGoogle Scholar
  60. Siegal T, Haim N (1990) Cisplatin-induced peripheral neuropathy. Frequent off-therapy deterioration, demyelinating syndromes, and muscle cramps. Cancer 66:1117–1123PubMedCrossRefGoogle Scholar
  61. Spencer JPE (2008a) Flavonoids: modulators of brain function? Br J Nutr 99:ES60–ES77PubMedGoogle Scholar
  62. Spencer JPE (2008b) Food for thought: the role of dietary flavonoids in enhancing human memory, learning and neuro-cognitive performance. Proc Nutr Soc 67:238–252PubMedCrossRefGoogle Scholar
  63. Ta LE, Schmelzer JD, Bieber AJ, Loprinzi CL, Sieck GC, Brederson JD, Low PA, Windebank AJ (2013) A novel and selective poly (ADP-ribose) polymerase inhibitor ameliorates chemotherapy-induced painful neuropathy. PloS One 8,e54161Google Scholar
  64. Ta LE, Espeset L, Podratz J, Windebank AJ (2006) Neurotoxicity of oxaliplatin and Cisplatin for dorsal root ganglion neurons correlates with platinum–DNA binding. Neurotoxicology 27:992–1002PubMedCrossRefGoogle Scholar
  65. Turan MI, Cayir A, Cetin N, Suleyman H, Turan IS, Tan H (2014) An investigation of the effect of thiamine pyrophosphate on Cisplatin-induced oxidative stress and DNA damage in rat brain tissue compared with thiamine: thiamine and thiamine pyrophosphate effects on Cisplatin neurotoxicity. Hum Exp Toxicol 33:14–21PubMedCrossRefGoogle Scholar
  66. Vardy J, Wefel JS, Ahles T, Tannock IF, Schagen SB (2008) Cancer and cancertherapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol 19:623–629PubMedCrossRefGoogle Scholar
  67. Walsh RN, Cummins RA (1976) The open-field test: a critical review. Psychol Bull 83:482–504PubMedCrossRefGoogle Scholar
  68. Windebank AJ, Grisold W (2008) Chemotherapy-induced neuropathy. J Peripher Nerv Syst 13:27–46PubMedCrossRefGoogle Scholar
  69. Youdim KA, Shukitt HB, Martin A, Wang H, Denisova N, Bickford PC, Joseph JA (2000) Short-term dietary supplementation of blueberry polyphenolics, beneficial effects on aging brain erformance and peripheral tissue function. Nutr Neurosci 3:383–397Google Scholar
  70. Zbarsky V, Datla KP, Parkar S, Rai DK, Aruoma OI, Dexter DT (2005) Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson’s disease. Free Radic Res 39:1119–1125PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Yassine Chtourou
    • 1
  • Brahim Gargouri
    • 1
  • Mohammed Kebieche
    • 2
  • Hamadi Fetoui
    • 1
    Email author
  1. 1.Laboratory of Toxicology and Environmental Health, UR11ES70, Sciences Faculty of SfaxUniversity of SfaxSfaxTunisia
  2. 2.Molecular Biology Laboratory, Faculty of Nature and Life SciencesUniversity of JijelJijelAlgeria

Personalised recommendations